12-2115244-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_000719.7(CACNA1C):​c.70C>T​(p.Arg24Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000152 in 1,578,244 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R24H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

5
8
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 3.65

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAdExome4 at 21 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.160C>T p.Arg54Cys missense_variant Exon 2 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.70C>T p.Arg24Cys missense_variant Exon 2 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000682152.1 linkc.19C>T p.Arg7Cys missense_variant Exon 1 of 6 ENSP00000506759.1 A0A804HHT8
CACNA1CENST00000480911.6 linkn.70C>T non_coding_transcript_exon_variant Exon 2 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152272
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000288
AC:
6
AN:
208464
AF XY:
0.0000443
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000321
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000218
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000147
AC:
21
AN:
1425972
Hom.:
0
Cov.:
31
AF XY:
0.0000184
AC XY:
13
AN XY:
704752
show subpopulations
African (AFR)
AF:
0.0000307
AC:
1
AN:
32532
American (AMR)
AF:
0.0000240
AC:
1
AN:
41592
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24674
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38224
South Asian (SAS)
AF:
0.0000371
AC:
3
AN:
80898
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50760
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5658
European-Non Finnish (NFE)
AF:
0.0000146
AC:
16
AN:
1092728
Other (OTH)
AF:
0.00
AC:
0
AN:
58906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152272
Hom.:
0
Cov.:
34
AF XY:
0.0000134
AC XY:
1
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41480
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.00000830
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Dec 31, 2012
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg24Cys (CGC>TGC): c.70 C>T in exon 2 of the CACNA1C gene (NM_000719.6). The Arg24Cys variant in the CACNA1C gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Arg24Cys results in a non-conservative amino acid substitution of a positively charged Arginine with a neutral, polar Cysteine at a position that is conserved across species. In silico analysis predicts Arg24Cys is possibly damaging to the protein structure/function. The NHLBI ESP Exome Variant Server reports Arg24Cys was not observed in approximately 6,000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. Nevertheless, no mutations in nearby codons have been reported in association with LQTS. With the clinical and molecular information available at this time, we cannot definitively determine if Arg24Cys is a disease-causing mutation or a rare benign variant. The variant is found in LQT panel(s). -

Long QT syndrome Uncertain:1
Aug 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 24 of the CACNA1C protein (p.Arg24Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with long QT Syndrome (PMID: 31737537). ClinVar contains an entry for this variant (Variation ID: 190675). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1C protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Sep 20, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R24C variant (also known as c.70C>T), located in coding exon 2 of the CACNA1C gene, results from a C to T substitution at nucleotide position 70. The arginine at codon 24 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in a Brugada syndrome cohort; however, clinical details were limited (Marschall C et al. Cardiovasc Diagn Ther, 2019 Oct;9:S292-S298). This missense alteration is located in a region that has a low rate of benign missense variation (Lek M et al. Nature. 2016 Aug 18;536(7616):285-91; DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth H.V. et al. 2009. Am.J.Hum.Genet. 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
CardioboostArm
Benign
0.00020
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.020
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.89
D
M_CAP
Benign
0.064
D
MetaRNN
Uncertain
0.50
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.91
D
MutationAssessor
Benign
0.0
.;.;N;.;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;.;.;.
PhyloP100
3.6
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-5.7
D;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.59
Sift
Uncertain
0.0020
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
0.0
D;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.95, 0.98, 0.99, 1.0, 0.99
.;.;P;.;D;P;D;P;D;D;D;P;D;D;P;P;D;.;P;D;.;.;.;.
Vest4
0.73, 0.61, 0.69, 0.62, 0.59, 0.61, 0.59, 0.59, 0.61, 0.69, 0.63, 0.60, 0.63, 0.58, 0.59, 0.71, 0.60, 0.67, 0.59, 0.61, 0.60, 0.72
MutPred
0.40
.;Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);Gain of catalytic residue at Y20 (P = 0);
MVP
0.84
MPC
2.1
ClinPred
0.50
D
GERP RS
5.8
PromoterAI
0.0049
Neutral
gMVP
0.71
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773211348; hg19: chr12-2224410; API